Qigen Fang
Yao Wu
Defeng Chen
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- Department of Head Neck and Thyroid, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
A Corrigendum on:
Incidence and Prognostic Significance of PD-L1 Expression in High-Grade Salivary Gland Carcinoma
By Fang Q, Wu Y, Du W, Zhang X, Chen D. (2021) Front Oncol. 11:701181. doi: 10.3389/fonc.2021.701181
In the published article, there was an error in affiliation order. Instead of “Department of Head Neck and Thyroid, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China”, it should be “Department of Head Neck and Thyroid, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: salivary gland carcinoma, PD-L1, immunotherapy, high-grade salivary gland carcinoma, survival
Citation: Fang Q, Wu Y, Du W, Zhang X and Chen D (2021) Corrigendum: Incidence and Prognostic Significance of PD-L1 Expression in High-Grade Salivary Gland Carcinoma. Front. Oncol. 11:836903. doi: 10.3389/fonc.2021.836903
Received: 16 December 2021; Accepted: 16 December 2021;
Published: 30 December 2021.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2021 Fang, Wu, Du, Zhang and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Qigen Fang, cWlnZW5mYW5nQDEyNi5jb20=